{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:46:02Z","timestamp":1787021162547,"version":"build-2736575974"},"reference-count":33,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Oncology Practice"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>Patients with and survivors of hematologic malignancies are particularly vulnerable to COVID-19 disease and complications. This study examined patients' vaccination attitudes and behaviors and their correlates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A two-wave survey was fielded in December 2020 and June 2021 among hematologic malignancy patients and survivors (N = 2,272). Demographic characteristics, intent to get vaccinated, vaccination status, attitudes toward vaccination, and level of trust in specific sources of information about COVID-19 vaccines were assessed. Descriptive statistics were calculated, and linear probability models were estimated to examine binary outcomes and their correlates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>In December 2020, before COVID-19 vaccines were available, 73% stated they were likely or very likely to get vaccinated if an FDA-approved vaccine became available; however, in June 2021 over 90% reported being vaccinated. Being younger, unmarried, trusting local faith leaders, and not having a bachelor's degree or more were negatively associated with getting vaccinated. Among those hesitant in December 2020, those who expressed a distrust of vaccines in general were least likely to get vaccinated. Being vaccinated in June 2021 was positively associated with the degree to which respondents trust their oncologist, federal agencies, and pharmaceutical companies. Oncologists and primary care physicians were reported as the most trusted sources for information about vaccines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>COVID-19 vaccine hesitancy remains a public policy concern even now, as additional boosters are recommended among vulnerable populations. Our findings suggest that patient trust in their treating physicians can play a critical role in promoting individual patient and public health goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/op.22.00338","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T15:59:40Z","timestamp":1668009580000},"page":"e167-e175","update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 Vaccine\u2013Related Beliefs and Behaviors Among Patients With and Survivors of Hematologic Malignancies"],"prefix":"10.1200","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5454-9793","authenticated-orcid":false,"given":"Jesper","family":"Akesson","sequence":"first","affiliation":[{"name":"The Behaviouralist"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa S.","family":"Weiss","sequence":"additional","affiliation":[{"name":"The Leukemia & Lymphoma Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5160-7721","authenticated-orcid":false,"given":"Maria","family":"Sae-Hau","sequence":"additional","affiliation":[{"name":"The Leukemia & Lymphoma Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-7785","authenticated-orcid":false,"given":"Gabriela","family":"Gracia","sequence":"additional","affiliation":[{"name":"Boston University, Questrom School of Business"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialanna","family":"Lee","sequence":"additional","affiliation":[{"name":"The Leukemia & Lymphoma Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Culp","sequence":"additional","affiliation":[{"name":"The Leukemia & Lymphoma Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Connell","sequence":"additional","affiliation":[{"name":"The Leukemia & Lymphoma Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Butterfield","sequence":"additional","affiliation":[{"name":"The Leukemia & Lymphoma Society"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena M.","family":"Conti","sequence":"additional","affiliation":[{"name":"Boston University, Questrom School of Business"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"b1","volume-title":"SEER Cancer Statistics Review, 1975-2017","author":"Howlader N","year":"2020"},{"key":"b2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2244"},{"key":"b3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.09.018"},{"key":"b4","volume-title":"COVID-19 More Deadly With Blood Than Solid Cancer: Study","author":"Banks MA","year":"2021"},{"key":"b5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824"},{"key":"b6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.006"},{"key":"b7","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(21)00418-5"},{"key":"b8","volume-title":"Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee*","author":"National Comprehensive Cancer Network","year":"2021"},{"key":"b9","volume-title":"COVID-19 Vaccine & Patients with Cancer","year":"2021"},{"key":"b10","first-page":"1296","volume":"39","author":"Greenberger L","year":"2021","journal-title":"Cancer Cell"},{"key":"b11","volume-title":"COVID-19 Vaccines and People with Cancer"},{"key":"b12","unstructured":"Evidence used to update the list of underlying medical conditions that increase a person\u2019s risk of severe illness from COVID-19. Centers for Disease Control and Prevention. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/evidence-table.html"},{"key":"b13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.01.046"},{"key":"b14","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06419-y"},{"key":"b15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153883"},{"key":"b16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050411"},{"key":"b17","volume-title":"Public Participation in a Medical Screening Program: A Socio-Psychological Study","author":"Hochbaum GM","year":"1958"},{"key":"b18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.07.056"},{"key":"b19","volume-title":"Updated Data on Blood Cancers","year":"2020"},{"key":"b20","volume-title":"KFF COVID-19 Vaccine Monitor: December 2020","author":"Hamel L","year":"2020"},{"key":"b21","volume-title":"KFF Covid-19 Vaccine Monitor"},{"key":"b22","volume-title":"KFF COVID-19 Vaccine Monitor: In Their Own Words, Six Months Later","year":"2021"},{"key":"b23","doi-asserted-by":"publisher","DOI":"10.3389\/fpos.2021.661257"},{"key":"b24","doi-asserted-by":"crossref","volume-title":"Hesitancy Towards a COVID-19 Vaccine and Prospects for Herd Immunity","author":"Thunstrom L","DOI":"10.2139\/ssrn.3593098"},{"key":"b25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-8246-3"},{"key":"b26","volume-title":"Increasing the Intent to Receive a Pandemic Influenza Vaccination: Testing the Impact of Theory-Based Messages","author":"Godinho C"},{"key":"b27","doi-asserted-by":"crossref","unstructured":"Guidry J: Framing and visual type: Effect on future Zika vaccine uptake intent. J Pub Health Res 30:1162, 2018","DOI":"10.4081\/jphr.2018.1162"},{"key":"b28","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101167"},{"key":"b29","volume-title":"KFF COVID-19 Vaccine Monitor: January 2021","author":"KFF"},{"key":"b30","volume-title":"Rethinking Vaccine Hesitancy in a Pandemic, a Discussion","volume":"10","author":"Medical and Addictions Work Group of the Interdivisional Task Force on the Pandemic American Psychological Association","year":"2022"},{"key":"b31","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-03961-y"},{"key":"b32","doi-asserted-by":"publisher","DOI":"10.3390\/bs11040056"},{"key":"b33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25594"}],"container-title":["JCO Oncology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/OP.22.00338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T18:01:29Z","timestamp":1676052089000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/OP.22.00338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1200\/OP.22.00338"],"URL":"https:\/\/doi.org\/10.1200\/op.22.00338","relation":{},"ISSN":["2688-1527","2688-1535"],"issn-type":[{"value":"2688-1527","type":"print"},{"value":"2688-1535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"2022-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}